Royce & Associates LP Sells 91,676 Shares of Transcat, Inc. $TRNS

Royce & Associates LP trimmed its position in shares of Transcat, Inc. (NASDAQ:TRNS – Free Report) by 21.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 339,995 shares of the scientific and technical instruments company’s stock after selling 91,676 shares during the period. Royce & Associates LP’s holdings in Transcat were worth $30,062,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in TRNS. BlackRock Inc. purchased a new position in Transcat in the second quarter worth approximately $67,445,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Transcat in the 2nd quarter valued at $37,106,000. Wellington Management Group LLP acquired a new stake in shares of Transcat in the 2nd quarter valued at $29,409,000. Riverbridge Partners LLC raised its holdings in shares of Transcat by 8.4% in the 3rd quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock valued at $19,404,000 after purchasing an additional 17,063 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Transcat by 3.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock worth $19,244,000 after purchasing an additional 9,266 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Stock Down 2.1%

Transcat stock traded down $2.25 during mid-day trading on Friday, hitting $104.08. The company had a trading volume of 91,195 shares, compared to its average volume of 203,565. The company has a quick ratio of 2.19, a current ratio of 2.57 and a debt-to-equity ratio of 0.38. Transcat, Inc. has a 1 year low of $50.23 and a 1 year high of $112.44. The business has a fifty day moving average of $89.01 and a 200 day moving average of $83.53. The stock has a market cap of $978.87 million, a price-to-earnings ratio of 216.84 and a beta of 0.61.

Transcat (NASDAQ:TRNS – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.19. The business had revenue of $97.09 million during the quarter, compared to the consensus estimate of $92.46 million. Transcat had a net margin of 1.26% and a return on equity of 6.14%. On average, sell-side analysts expect that Transcat, Inc. will post 2.06 earnings per share for the current fiscal year.

Insider Activity at Transcat

In related news, CEO Jaime A. Irick bought 2,275 shares of the company’s stock in a transaction that occurred on Thursday, November 5th. The shares were purchased at an average cost of $101.26 per share, with a total value of $230,366.50. Following the transaction, the chief executive officer directly owned 2,275 shares of the company’s stock, valued at approximately $230,366.50. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on TRNS. Oppenheimer upgraded shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 target price for the company in a research note on Wednesday, November 4th. CJS Securities began coverage on Transcat in a research note on Tuesday, October 27th. They issued an “outperform” rating and a $115.00 price target on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research note on Tuesday, August 25th. Zacks Research raised Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 5th. Finally, Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 price objective for the company in a research report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Transcat currently has a consensus rating of “Moderate Buy” and an average target price of $108.33.

Check Out Our Latest Stock Analysis on Transcat

Transcat Profile

(Free Report)

Transcat, Inc. provides calibration and related services, including instrument repair, inspection and compliance support. Its services help customers maintain the accuracy and reliability of equipment used in regulated and quality-sensitive operations. The company also distributes professional-grade test, measurement and control instruments from a range of manufacturers. Its offerings include equipment used to measure and monitor variables such as pressure, temperature, electrical signals and humidity.

Further Reading

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.